To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Less than six months after ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Dr. Culleton brings over two ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Outgoing CEO Tim Bertram's total ...
- Brings more than 20 years of academic and industry experience with extensive expertise in kidney disease - WINSTON-SALEM, N.C., July 17, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ...
Welcome, everyone, to the next session of the Citi's Biopharma back-to-school Summit. So we are literally back to school, checking up on all the companies. So the next one is it's my pleasure to ...
Dr. Bruce Culleton: So I’ll address your second question first, Yigal, if I could. So first, we believe based upon the data that we see, that REACT works across multiple different patient groups. And ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of ProKidney's money went ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results